APA

Tsavachidou D., Coleman M. L., Athanasiadis G., Li S., Licht J. D., Olson M. F. & Weber B. L. (20040930). SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant. : Cancer research.

Chicago

Tsavachidou Dimitra, Coleman Mathew L, Athanasiadis Galene, Li Shuixing, Licht Jonathan D, Olson Michael F and Weber Barbara L. 20040930. SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant. : Cancer research.

Harvard

Tsavachidou D., Coleman M. L., Athanasiadis G., Li S., Licht J. D., Olson M. F. and Weber B. L. (20040930). SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant. : Cancer research.

MLA

Tsavachidou Dimitra, Coleman Mathew L, Athanasiadis Galene, Li Shuixing, Licht Jonathan D, Olson Michael F and Weber Barbara L. SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant. : Cancer research. 20040930.